Abstract | During the past decade, genome-wide association studies (GWAS) have been used to successfully identify tens of thousands of genetic variants associated with complex traits and diseases. These studies have produced extensive repositories of genetic variation and trait measurements across large numbers of individuals, providing tremendous opportunities for further analyses. However, privacy concerns and other logistical considerations often limit access to individual-level genetic data, motivating the development of methods that analyse summary association statistics. Here, we review recent progress on statistical methods that leverage summary association data to gain insights into the genetic basis of complex traits and diseases.
1
. These studies have produced extensive databases of genetic variation (typically at the level of common single nucleotide polymorphisms (SNPs) included on geno typing arrays) in large numbers of individuals across hundreds of complex traits. Further analyses of these data can yield important insights into the genetics of complex traits, but privacy concerns and other logistical considerations often restrict access to individual-level data. Nevertheless, summary association statistics are often readily avail able and can be used to compute z-scores (FIG. 1) . Here, we define summary association statistics as per-allele SNP effect sizes (log odds ratios for case-control traits) together with their standard errors, although we note that some applications may also require allele frequencies. A list of selected publicly avail able summary association statistics from large GWAS is provided in TABLE 1. Analyses of summary statistics also offer advantages in computational cost, which does not scale with the number of individuals in the study. These advantages have motivated the recent development of many new methods for analysing summary association data, often in conjunction with linkage disequilibrium (LD) information from a population reference panel such as 1000 Genomes 2 . Here, we review these summary statistic-based methods. First, we review methods for performing single-variant association tests, including meta-analysis, conditional association and imputation using summary statistics. Second, we review methods for performing gene-based association tests by incorporating transcriptome reference data or aggregating signals across multiple rare variants. Third, we review methods for fine-mapping causal variants, including the integration of functional annotation and/or trans-ethnic data. Fourth, we review methods for constructing polygenic predictions of disease risk and inferring polygenic architectures. Finally, we review methods for jointly analysing multiple traits. We conclude with a discussion of research areas for which further work on summary statistic-based methods is needed.
Single-variant association tests
Meta-analysis using fixed-effects or random-effects models. Large consortia often combine multiple GWAS into a single aggregate analysis to boost power for discovering SNP associations with small effects. Studies are combined either by jointly analysing summary association results from each study (meta-analysis) or by re-analysing individual-level data across all studies (mega-analysis) 3 . It has been shown that a meta-analysis attains similar power for association as a mega-analysis, with fewer privacy constraints and logistical challenges (because only summary association data are shared across studies) 4 . A meta-analysis is usually performed using fixed-effects approaches, which assume that true effect sizes are the same across studies. Under the assumption that causal effect sizes may differ across studies, this heterogeneity can be explicitly modelled using random-effects methods. These methods include
Individual-level data
Genome-wide single nucleotide polymorphism genotypes and trait values for each individual included in a genome-wide association study.
Summary association statistics
Estimated effect sizes and their standard errors for each single nucleotide polymorphism analysed in a genome-wide association study.
Meta-analysis
A method for combining data from different studies in which summary association statistics from each study are jointly analysed.
Mega-analysis
A method for combining data from different studies in which individual-level data from each study are merged and jointly analysed.
an extra variance term in the model to account for hetero geneity. Traditional random-effects methods allow for heterogeneity under the null model, leading to low power even when heterogeneity is present. This limit ation of traditional random-effects methods motivated the development of a random-effects method based on a null model of no heterogeneity 5 , which has increased power over traditional random-effects methods. Under this framework, a statistical test against a null model of no heterogeneity can be viewed as a summation of a fixed-effect component and a heterogeneity component, thus connecting fixed-effects and random-effects meta-analyses 5 . Subsequent work has introduced the concept of posterior probability for each study to have an effect; this concept can aid interpretation and power under the assumption that a subset of studies have a negligible effect on the trait 6 .
Conditional association using LD reference data. Conditional association, in which the association between a SNP and a trait is evaluated after conditioning on the top SNP at a locus, can be used to identify multiple signals of association at a previously identified GWAS locus. Conditional association methods have traditionally required individual-level data to jointly fit multiple SNPs. Recent work has shown that conditional and joint association analyses of multiple SNPs can be approximated using only summary association statistics together with LD information estimated from a population reference panel such as 1000 Genomes 7
. This finding has enabled the discovery of new secondary associations at known loci for height, body mass index and other complex traits and diseases, thus increasing the variance explained by GWAS associations for these traits [8] [9] [10] . For example, in a recent GWAS of height, an approximate conditional analysis using summary association statistics data identified 697 genomewide significant associations, including 34 secondary associations with r 2 >0.1 to a more significant SNP at the same locus (see supplementary 
Imputation using summary association statistics.
A standard approach to boost association power in GWAS is to leverage LD information from a population reference panel to impute genotypes at variants not typed in the study 11 . Imputation is traditionally performed using individual-level data, which requires substantial computational resources. Moreover, imputation can be logistically cumbersome when new reference panels become available, particularly for large consortia combining data from multiple studies. As an alternative to imputation using individual-level data, approaches have been developed to perform imputation directly at the level of summary statistics [12] [13] [14] [15] [16] [17] [18] (providing an alternative to other multivariate tests 19, 20 ). The key insight of these approaches is that LD induces correlations between z-scores, which can be modelled using a multivariate normal (MVN) distribution with the variance equal to the LD correlation matrix 21 . Note that an adjustment in the LD computation is needed for z-scores estimated using mixed models 22 . Thus, z-scores at untyped SNPs can be imputed from observations at typed SNPs using conditional means and variances of the MVN distribution. Imputation using summary statistics recovers >80% of the information from imputation using individual-level data at common variants [14] [15] [16] . This approach is also practical and efficient because the imputed summary statistics are linear combinations of the observed statistics
. However, imputation using summary statistics cannot capture nonlinear relationships between SNPs, which are modelled using haplotypes in imputation from individual-level data.
Conditional association and imputation using summary statistics crucially rely on accurate LD information from a population reference panel. Even in the best case, when the reference population closely matches the GWAS population, the relatively small size of reference panels for which LD information is publicly available (typically hundreds or at most thousands of individuals) makes accurate estimation of a large number of LD parameters a challenge. This motivated approaches for the regularization of the estimated LD matrix, both to maximize accuracy and to ensure robustness in the case of imputation using summary statistics, particularly as mis-estimation of the variance of imputed statistics can lead to false-positive associations. A simple approach to regularization is to set all correlations Nature Reviews | Genetics Includes specialty genotyping array data; not suitable for analysis using linkage disequilibrium score regression and its extensions.
Summary LD information
(summary linkage disequilibrium information). In-sample correlations between each pair of typed single nucleotide polymorphisms analysed in a genome-wide association study; can be restricted to proximal pairs of typed SNPs to limit the number of pairs of SNPs.
Transcriptome-wide association studies (TWAS) . Studies that evaluate the association between the expression of each gene and a trait of interest; predicted expression may be used instead of measured expression to improve practicality.
Mendelian randomization
A method that uses significantly associated single nucleotide polymorphisms as instrumental variables to quantify causal relationships between two traits.
between distal SNPs to zero based on a fixed distance threshold 7 or on approximately independent LD blocks inferred from the data 23 . An alternative is to specify a prior distribution and to compute Bayesian posteriors 12 ; data can be combined across multiple ancestry reference panels to further boost accuracy 17, 18 . Singular value decomposition-based approaches for LD regularization have also been proposed in other contexts 10 . In general, the accuracy of conditional association and imputation using summary statistics is reduced for low-frequency variants and when the LD structure between typed and imputed SNPs is mis-specified (for example, when the ancestry of the GWAS sample does not exactly match the reference panel). We note that concerns about falsepositive associations in imputation using summary statistics can be avoided entirely via the release of in-sample summary LD information.
Gene-based association tests Gene-based association using transcriptome reference data. GWAS risk variants are significantly enriched for genetic variants that affect gene expression, that is, expression quantitative trait loci (eQTLs) 24 . This motivates the paradigm of transcriptome-wide association studies (TWAS), which evaluate the association between the expression of each gene and a complex trait of interest. Owing to the limited availability of very large samples with measured gene expression and trait values, initial TWAS approaches integrated eQTL and GWAS data to identify susceptibility genes either by matching the association signals [25] [26] [27] , by mediation analyses 28 or by assessing whether the same causal variant affects both gene expression and trait under a single causal variant model [29] [30] [31] . More recent studies have leveraged predicted expression to improve the power of TWAS. Under this paradigm, transcriptome reference data are used to predict gene expression in the GWAS dataset (for example, using cis SNPs within 1 Mb of the transcription start site), followed by a test for association between the predicted expression and trait. As an alternative to TWAS using individual-level data 32 , TWAS using predicted expression can also be performed using only summary association statistics and summary LD information [33] [34] [35] . These studies used expression predictors that do not account for LD 33 or account for LD and allow for sparsity in eQTL effect sizes 34 , or used the top eQTL at the locus 35 . The key intuition is that the correlation between a weighted linear combination of SNPs (that is, predicted gene expression) and a trait is equivalent to a weighted linear combination of correlations between SNPs and a trait (that is, summary association statistics from GWAS) (FIG. 2) . Because TWAS using predicted expression is conceptually similar to a test for non-zero genetic covariance between gene expression and a trait 34 , it can also be performed via a two-sample Mendelian randomization from summary statistics 35 . TWAS using predicted expression can increase power over a standard GWAS when there exist multiple causal variants whose effect on a trait is mediated through expression. TWAS also reduce the multiple hypothesis burden by testing tens of thousands of genes instead of millions of SNPs. TWAS using predicted expression typi cally use individual-level transcriptome reference data to predict gene expression, but can also be performed using only summary association statistics between SNPs and gene expression, albeit with a reduction in power 34 . The potential power gains of TWAS are underscored by the recent identification of 71 new susceptibility genes across 28 complex traits, of which 17 have no GWAS association within 1 Mb (REF. 36 ). However, TWAS are under powered compared to standard GWAS when the true biological mechanism is independent of gene expression or when expression data in the most relevant tissue are not available.
Rare variant association tests. Although most GWAS of complex traits and diseases have focused on common variants that are typed on genotyping arrays or imputed from population reference panels, rare variant associations may also provide a rich source of biological insights, particularly for traits under strong negative selection 37, 38 . Because association tests of individual rare variants are likely to be underpowered, rare variant association tests generally aggregate evidence for association across multiple rare variants at a locus. In exome sequencing studies (or exome array studies), rare variants are aggregated at the gene level, making the gene the unit of association. This process can be performed using either burden tests or overdispersion tests, although hybrid omnibus tests are also possible 39 . Recent studies 
Conditional association using LD reference data
We estimate the joint effects of all SNPs using least-squares as
, where σ 2 J is the residual variance in the joint analysis. However, in a standard genome-wide association study, each SNP is marginally tested one at a time, which can be expressed in matrix form as
, where D is the (nearly constant) diagonal matrix of V and σ 2 M is the residual variance in the marginal analysis. It follows that
Summary statistic imputation using LD reference data Let 
. The mean and variance of the conditional distribution can be used to impute summary association statistics at untyped SNPs.
Burden tests
Gene-based rare variant tests in which all rare variants in a gene are assumed to have the same direction of effect.
Overdispersion tests
Gene-based rare variant tests in which rare variants in a gene are assumed to impact trait in either direction.
Posterior probability of causality
The inferred probability that a single nucleotide polymorphism is causal based on association data and optional prior information.
have shown that both burden tests and overdispersion tests can be performed using only summary association stat istics from each rare variant, together with summary LD information [40] [41] [42] 
. Briefly, burden tests are computed as weighted sums of single-variant z-scores whereas overdispersion tests are computed as weighted sums of squared single-variant z-scores (analogous to previous work on common variant overdispersion tests using summary statistics 19, 20 ), with summary LD information used to specify appropriate null distributions in each case. However, a key limitation of these studies is that they require the use of in-sample summary LD information in preference to reference LD information to ensure appropriate null distributions and to avoid false-positive associations. Thus, in contrast to summary statistic-based methods for common variants (see above), both summary association statistics and insample summary LD information are required for these methods to be useful (see Conclusions). An additional limitation is that for case-control traits, asymptotic null distributions may not be valid when variant counts or case or control sample sizes are small, necessitating careful scrutiny of quantile-quantile plots.
Fine-mapping Fine-mapping using posterior probabilities of causality. Statistical fine-mapping aims to identify the causal variant (or variants) that is driving a GWAS associ ation signal, enabling functional experiments to vali date biological function. A straightforward approach to fine-mapping is to prioritize variants based on the strength of the marginal association statistics (that is, ranking P values) 43 . This strategy is effective in the case of a single causal variant but can be suboptimal when multiple causal variants are present because the SNP with the top P value at the locus may be tagging multiple causal variants. An alternative is to compute the posterior probability of causality for every SNP in the region based on the likelihoods of the observed z-scores conditional on each possible set of causal variant (or variants) 44 . These posterior probabilities can be used to construct a credible set of SNPs, defined as the smallest set of SNPs that contains the true causal vari ant with a given probability (typically 90% or 99%). Initial studies approximated the posterior probabilities of causality under a single causal variant assumption. Under this assumption, posterior probabilities of causality can be estimated from z-scores without the need for LD information 45 ; this approach is both practical and computationally efficient but suboptimal when multiple causal variants are present.
More recent studies have computed posterior probabilities of causality under a multiple causal variant assumption 46 . As in the case of imputation using summary statistics, the likelihoods of the observed z-scores can be computed based on the MVN distribution with variance equal to the LD correlation matrix, with LD estimated from population reference panels using regularization techniques. In contrast to imputation using summary stat istics, which uses the null model of no associ ation (that is, a mean of 0 in the MVN), in fine-mapping the mean is a function of causal effect sizes, which can be heuristically approximated or integrated out using conjugate priors 46,47 . These methods often restrict computations to a maximum number of causal variants (for example, three or six); more recent studies have shown that further efficiencies can be achieved through matrix factorizations 48 or stochastic search 49 . Methods that model multiple causal vari ants generally improve the accuracy (and calibration) of credible sets at loci with multiple causal variants [46] [47] [48] [49] [50] , with very limited reductions in accuracy at loci with only a single causal variant [46] [47] [48] [49] [50] [51] [52] . A less accurate alternative is to use conditional association analysis to detect multiple signals of association 7, 53, 54 followed by an estimation of posterior probabilities of causality under a single causal variant assumption for each independent signal. In this case, special care is required in specifying the boundaries of each independent signal and the threshold for the conditional test.
Leveraging functional annotation data. Fine , with a recent study using a multiple causal variant model 46 to incorporate functional annotation data 47 . In an analysis of Figure 2 | TWAS using predicted expression and summary data. Transcriptome-wide association studies (TWAS) using predicted expression and summary data follow two steps. First, transcriptome reference data are used to build a linear predictor for gene expression, typically using single nucleotide polymorphisms (SNPs) from the 1 Mb local region around the gene with regularized effect sizes (for example, using a Bayesian sparse linear mixed model 81 ). Second, this predictor is applied to summary genome-wide association z-scores, and gene-trait association z-scores are computed, testing the null model of no association between a gene and a trait. eQTL, expression quantitative trait loci; LD, linkage disequilibrium. Nature Reviews | Genetics SNP LD (V) rheumatoid arthritis summary association data, integrative fine-mapping using this approach reduced the average size of 90% credible sets by 10% 61 . In addition to increasing fine-mapping accuracy, these studies have also provided insights into polygenic architectures (see below) by identifying tissue-specific functional annotations that are enriched for causal disease signals. This result can also be achieved by conducting fine-mapping without integrating functional annotation data (typically under a single causal variant assumption) and then overlapping the resulting credible sets with functional annotation data to assess enrichment [62] [63] [64] . Future integrative methods could increase fine-mapping resolution by integrating probabilistic functional annotations (for example, peak intensities of ChIP-seq (chromatin immunoprecipitation followed by sequencing) results) or modelling the strength of association between SNPs and chromatin marks in population-based studies 65, 66 .
5 2 z-scores (Z) Genotypes (G)

A T G T C A A C T G C T G A C
Trans-ethnic fine-mapping. Fine-mapping accuracy can also be improved by leveraging differences in LD patterns across continental populations that have arisen due to differences in demographic events such as population bottlenecks [67] [68] [69] [70] (FIG. 3) . Intuitively, the set of tag SNPs linked to a causal variant will vary across populations; thus, aggregating evidence of association across populations will dilute signals from tag SNPs and strengthen signals from causal variants. A standard approach to combining information across multiple studies is to compute posterior probabilities of causality from fixed-effects meta-analysis results 67,69, 71, 72 . Alternatively, posterior probabilities can be computed from the results of random-effects trans-ethnic meta-analysis methods 64, 68 . These approaches assume a single causal variant and thus do not require LD information from the underlying populations. More recent studies have introduced hierarchical probabilistic models that allow for multiple causal variants while incorporating LD information from population reference panels 61 . These studies assume that causal variants are shared across populations but allow for heterogeneity in effect sizes across populations and can also incorporate functional annotation data to further increase fine-mapping accuracy 61 . In an analysis of rheumatoid arthritis summary association data in Europeans and Asians (see above), trans-ethnic fine-mapping reduced the average size of 90% credible sets by 25% and by 32% when also integrating functional annotation data 61 .
Polygenicity of complex traits
Polygenic risk prediction. Although the main focus of complex disease genetics is to gain insights into disease biology, genetics can also be leveraged to build predictions of disease risk, which may become clinically useful as sample sizes increase 73, 74 . A landmark study of schizophrenia showed that polygenic risk scores produced predictions of schizophrenia risk in validation samples that were significantly better than random, and far more accurate than those based on the single genome-wide significant locus identified in the study 75 . This study provided an early demonstration of the advantages of incorporating markers that do not attain genome-wide significance into polygenic risk scores to improve the prediction accuracy for polygenic traits. An important issue in computing polygenic risk scores is that of LD between markers, which has historically been addressed by LD pruning -either without regard for P values 75 or via informed LD pruning 76 (also known as clumping), which preferentially retains markers with more significant P values. More recent work has shown that explicitly modelling LD using an LD reference panel and estimating posterior mean causal effect sizes can improve prediction accuracy from summary statistics 77 . An alternative to summary statistic-based methods is to fit effect sizes of all markers simultaneously using best linear unbiased prediction (BLUP) methods and their extensions [78] [79] [80] , which require individual-level training data. Fitting all markers simultaneously is theoretically more appropriate and can produce more accurate predictions, although the relative advantage is small when overall prediction accuracies are modest
.
In their simplest form, polygenic risk scores and BLUP methods assume infinitesimal (Gaussian) architectures in which all markers are causal. However, these methods have been extended to increase prediction accuracy in the case of non-infinitesimal architectures. 
Burden tests
Burden tests assume that all rare variants in a candidate gene have the same direction of effect. Burden tests may either assume that standardized effect sizes are the same for each rare variant 112 (that is, per-allele effect sizes are proportional to
where p i is the allele frequency), or apply weights or thresholds based on allele frequency or functional information 113, 114 . If w is an M × 1 vector of weights for each rare variant (including zero weights for rare variants excluded by a threshold), the test statistic for a weighted burden test is T burden = w T Z with null distribution T burden~N (0,w T Vw). This test statistic can naturally be extended to a meta-analysis of burden tests from multiple cohorts (via inverse-variance weighting), and can be extended to variable threshold tests and binary traits [40] [41] [42] .
Overdispersion tests
Overdispersion tests assume that rare variants in a candidate gene can affect a complex trait in either direction, and can be computed as weighted sums of squared single-variant test statistics 115, 116 . . This test statistic can be extended to a meta-analysis of overdispersion tests from multiple cohorts (via inverse-variance weighting), and can be extended to binary traits [40] [41] [42] .
LD score regression
A method of assessing trait polygenicity by regressing χ 2 association statistics against linkage disequilibrium (LD) scores for each single nucleotide polymorphism (SNP), computed as sums of squared correlations of each SNP with all SNPs including itself.
Improvement of polygenic risk scores has been accomplished by restricting markers to those below a P value threshold 75 or estimating posterior mean causal effect sizes under a point-normal prior 77 . Increased prediction accuracy for BLUP methods has been achieved by estimating (joint-fit) posterior mean causal effect sizes under a normal mixture prior 81, 82 . Although polygenic risk scores must await even larger training sample sizes to attain clinical utility, appreciable prediction accuracies have been achieved for some traits, including a Nagelkerke coefficient of determination (R 2 ) of 0.25 (area under the curve: 75%) for schizophrenia 77 . A crucial caveat is to avoid non-independence of training and validation samples (for example, due to cryptic relatedness or shared population stratification) when constructing and evaluating polygenic risk scores. Non-independence of training and validation samples could cause prediction accuracy to be overstated relative to what could be achieved in an independent validation sample 77, 83 .
Inferring polygenic architectures.
It is becoming increasingly clear that most complex traits and diseases have highly polygenic architectures, with a large number of causal variants with small effects. To understand these polygenic architectures, it is of interest to infer parameters such as the heritability explained by SNPs and the number of variants with non-negligible effects on the trait. Both of these quantities have been estimated using accuracies of polygenic risk scores (see above), as a function of the P value threshold that is used to constrain the set of employed markers 75, 76 . Computing polygenic risk scores requires individuallevel data in the validation cohort, implying that these methods are not strictly summary statistic based. Recent work has shown that the information in polygenic risk scores can be derived from summary-level data in the training and validation cohorts to estimate the heritability explained by SNPs and the number of causal variants 84 . A limita tion of this approach is that SNPs are assumed to be uncorrelated, which can be approximately achieved by LD pruning but precludes analyses of dense marker panels. The heritability explained by SNPs can alternatively be estimated from the slope of LD score regression 85 , leveraging the fact that SNPs with higher LD scores are expected to contain more polygenic signals 86 . This approach explicitly allows for LD Nature Reviews | Genetics between SNPs and can distinguish between polygenicity and confounding. However, the approach assumes a linear model that may not hold in practice and makes strong assumptions about effect sizes of rare variants that only enable robust estimates for common variants. Another recent method models LD while treating SNP effects as fixed rather than random (similar to the method reported in REF. 84 ), enabling estimation of heritability explained by common SNPs in local regions as well as genome-wide 10 . Overall, summary statistic-based methods provide a useful alternative to methods for estimating heritability explained by SNPs from individual-level data using restricted maximum likelihood (REML) and its extensions 87, 88 . The increasing availability of functional annotation data (see above) can also be used to identify functional annotations that are enriched for polygenic signals of disease heritability. A recent study accomplished this goal using a Bayesian hierarchical model that splits the genome into blocks and incorporates functional annotations both coarse-scale at the level of blocks and finescale at the level of SNPs 59 . This study was the first to quantify polygenic enrichments for cell type-specific chromatin marks and DNase I hypersensitivity sites across a broad set of complex traits and diseases. For example, polygenic signals for platelet volume and platelet count were enriched at DNase I hypersensitivity sites in CD34
+ cells (which are on the cell lineage that lead to platelets), and polygenic signals for Crohn's disease were depleted at repressed chromatin in lymphoblastoid cell lines. Functional enrichments can alternatively be estimated by stratified LD score regression 89 , which generalizes LD score regression 85 to regress χ 2 statistics for each SNP against LD scores with each functional category. Fine-mapping methods can also estimate functional enrichments, although these ana lyses are often restricted to disease-associated loci 47, 52, 61 . Notably, all of these summary statistic-based methods have been applied to a large number of overlapping functional annotations, whereas methods that analyse individual-level genotypes have only been applied to a small number of non-overlapping functional annotations 88, 90 . In addition, stratified LD score regression is not limited by the single causal vari ant per block assumption of the Bayesian hierarchical model, increasing power in settings of highly polygenic traits 89 . Application of stratified LD score regression identified significant cell type-specific enrichments for many highly polygenic traits, including enrichments for histone marks in the brain for smoking behaviour and educational attainment 89 , even though the summary statistics analysed contained only one and three genome-wide significant loci for smoking behaviour and educational attainment, respectively. One limitation of stratified LD score regression is its limited power for functional categories spanning a small percentage of the genome; thus, additional work in this area is required. As both summary statistic and functional annotation datasets grow larger and richer, identifying enriched functional annotations using summary statistic data will likely continue to be a fruitful endeavour.
Box 3 | Polygenic risk prediction using summary versus individual-level data
Suppose that polygenic risk prediction for a quantitative trait is conducted using a training cohort with N unrelated samples, using M unlinked markers with single nucleotide polymorphism (SNP) heritability 7 equal to h g 2 . We initially consider two polygenic risk prediction methods that assume infinitesimal (Gaussian) architectures: polygenic risk scores computed using marginal effects at all markers with no P value thresholding (PRS all ), and fitting effect sizes of all markers simultaneously via best linear unbiased prediction (BLUP). We note that PRS all requires only summary statistics from the training cohort, whereas BLUP requires individual-level data. Prediction accuracy (coefficient of determination; R 2 ) for each method is given by 83, 117 
These equations can naturally be extended to linked markers (using the effective number of unlinked markers 108 ) and case-control traits (using observed-scale SNP heritability 118 ). The relative advantage of BLUP over PRS all is small when prediction R 2 is small in absolute terms, but grows larger when prediction R 2 is larger. This effect is illustrated in the figure, which shows prediction R 2 at various training sample sizes based on M = 60,000 unlinked markers and a SNP heritability of h g 2 = 0.5. These results generalize to non-infinitesimal extensions of polygenic risk scores 75, 77 and BLUP 81, 82 ; in the latter case, the noise reduction from fitting all markers simultaneously remains equal to 1 − R 
BLUP PRS all
Pleiotropy
The existence of a genetic variant (or variants) that affects more than one trait.
Genetic correlation
The signed correlation across single nucleotide polymorphisms between causal effect sizes for two traits.
Cross-trait analyses Many complex traits and diseases have a shared genetic aetiology, which can be either via a shared genetic variant (or variants) with non-zero effect sizes ( pleiotropy) or via a correlation between causal effect sizes (genetic correlation). Indeed, many instances of genetic variants with pleiotropic effects on multiple traits have been identi fied [91] [92] [93] [94] [95] [96] . A recent study applied a Bayesian framework to summary association statistics from pairs of traits to estimate, at each locus in the genome, the probability that an associated variant has pleiotropic effects on both traits 97 . Pleiotropic SNPs can also be used as instrumental variables in Mendelian randomization analyses from summary statistics [98] [99] [100] , with one such analysis showing that increased body mass index causally increases triglyceride levels 97 . An alternative approach to assessing the genetic overlap between two traits is to estimate the correlation between causal effect sizes across the two traits. Genome-wide genetic correlations can be estimated from individual-level data using bivariate REML 101 . A recent study estimated genome-wide genetic correlations from summary data using the information in polygenic risk scores 84 . However, this approach required LD pruning of the data, which may lead to upwards bias 84 . Another recent study estimated genome-wide genetic correlations from summary data using crosstrait LD score regression 102 , which generalizes LD score regression to regress products of z-scores against LD scores for each SNP. This method produced estimates that were highly concordant with those from individual-level data 101 . Fitting the underlying MVN model using maximum likelihood instead of linear regression has produced promising results in applications to estimate cross-trait and cross-population genetic correlations, and may also prove useful in other settings 103 . Although genetic correlation analyses restricted to associ ated variants have also produced important findings 97 , the power of methods that leverage polygenic signals in genome-wide data is underscored by the discovery of significant genetic correlations involving traits with zero or few genome-wide significant loci, including a significant negative genetic correlation between smoking behaviour and educational attainment 102 . Notably, recent work has shown that association statistics for unmeasured traits can be computed using summary statistics from genetically correlated traits 104, 105 .
Conclusions
Recently developed methods have made it possible to leverage summary association statistics to perform a wide range of analyses, many of which previously required individual-level data. As the availability of summary association statistics continues to grow (TABLE 1) , summary statistics will continue to be broadly used in analyses involving single-variant association tests, gene-based association tests, fine-mapping, polygenic prediction and inferring polygenic architectures, and cross-trait analyses. The use of summary data will entail a loss of accuracy in some applications such as imputation and polygenic risk prediction. For imputation, methods that analyse individual-level data can use haplotypes to model nonlinear structure, whereas for polygenic risk prediction, methods that analyse individual-level data can reduce noise by fitting all markers simultaneously. However, when summary statistics are available in larger sample size than individual-level data, the advantage of larger sample size will outweigh those limitations. In addition, there are some settings when summary statistic-based methods are the method of choice even when individual-level data are available, such as identifying functional annotations that are enriched for heritability, for which methods that analyse individual-level data cannot currently handle a large number of overlapping annotations.
Despite considerable recent progress, there are some areas in which further research on summary statistic-based methods is needed. As population reference panels grow, more accurate modelling of rare and low-frequency variants will become possible, and it will be important to assess the limits of such efforts. It is also of interest to develop methods for inferring polygenic architectures from summary statistics that permit different relationships between allele frequency and effect size. Identifying functional annotations that are enriched for heritability is an application that is particularly likely to produce important biological insights; however, for such applications there is a need for new methods that are adequately powered for functional categories spanning a small percentage of the genome. As the number of functional annotations continues to increase, the integration of such data poses computational and statistical challenges in disentangling the correct functional annotations among many correlated ones.
We conclude by emphasizing the importance of making summary association statistics publicly avail able. A 2012 editorial in Nature Genetics asked its authors to publish or deposit in databases summary association statistics for all SNPs analysed 106 . This editorial elicited a broad impact on the set of publicly available summary statistics in the years that followed (TABLE 1) . The public release of summary statistics is a useful compromise in situations when sample consent restrictions or privacy concerns preclude the release of individual-level data in a public repository. Even though the release of summary statistics can in principle lead to privacy concerns 107 , more recent work has shown that such privacy attacks have low power when the summary sample size exceeds the effective number of independent markers (currently estimated at 60,000 in typical GWAS datasets 108 ), implying that privacy concerns should not preclude the public release of summary statistics from large studies [109] [110] [111] . Indeed, some recent studies have created web portals where summary data can be publicly accessed and visualized 63 . Finally, we note the potential benefits of publicly releasing summary statistics that include summary LD information (that is, correlations) between each pair of proximal SNPs. However, the optimal approach to aggregating summary LD information across multiple cohorts in large-scale meta-analyses remains unclear, motivating the need for future work in this area.
